Author name: David Tuller

Trial By Error: Another Nudge to Mahana’s Gasteroenterology Advisers

By David Tuller, DrPH Back in February, I wrote to some science advisers to Mahana Therapeutics to alert them to the company’s unjustified claims about the impact of its web-based program on the symptoms of irritable bowel syndrome. Two of them–Dr Peter Lu and Dr Carlo di Lorenzo–are gastroenterology specialists at Nationwide Children’s Hospital in …

Trial By Error: Another Nudge to Mahana’s Gasteroenterology Advisers Read More »

Trial By Error: More on the Mahana Mess…

If you appreciate this piece and/or my work in general, here’s a link to my current UC Berkeley crowdfunding effort: https://crowdfund.berkeley.edu/project/20159 ********** By David Tuller, DrPH Today I sent a third letter to Dr Mel Heyman, a prominent gastroenterologist at the University of California, San Francisco. Dr Heyman is one of Mahana Therapeutics’ science advisers. I’ve …

Trial By Error: More on the Mahana Mess… Read More »

Trial By Error: Oxford Health Blinks, Removes Pamphlet on Post-COVID Illness

By David Tuller, DrPH In this traumatic time, small victories should be savored. Last week, I noticed a tweet from patient and advocate Tom Kindlon about a pamphlet from the Oxford Health NHS Foundation Trust, the entity that oversees NHS services in the Oxford region. Other patients and advocates also flagged it on social media …

Trial By Error: Oxford Health Blinks, Removes Pamphlet on Post-COVID Illness Read More »

Trial By Error: My FOI Letter about Oxford’s Post-COVID-19 Fatigue Pamphlet

If you appreciate this piece and/or my work in general, here’s a link to my current UC Berkeley crowdfunding effort: https://crowdfund.berkeley.edu/project/20159 ********** By David Tuller, DrPH As I reported yesterday (oops!–it was Thursday, not yesterday–this is a correction made a few minutes after posting!), the Oxford Health NHS Foundation Trust, which oversees NHS services in the …

Trial By Error: My FOI Letter about Oxford’s Post-COVID-19 Fatigue Pamphlet Read More »

Trial By Error: A Follow-Up to the Follow-Up Letter to Mahana

By David Tuller, DrPH On the Mahana Therapeutics website, Robert Paull, the CEO and co-founder, explains in a statement that his personal interest in developing treatments for GI problems arose out of the longtime suffering of a family member. His account is heartfelt and compelling. Unfortunately, Mr Paull and his company have placed their bets …

Trial By Error: A Follow-Up to the Follow-Up Letter to Mahana Read More »

Scroll to Top